bf/NASDAQ:DYN_icon.png

NASDAQ:DYN

Dyne Therapeutics

  • Stock

USD

Last Close

28.75

17/05 20:00

Market Cap

1.30B

Beta: 0.24

Volume Today

1.32M

Avg: 383.32K

PE Ratio

−6.54

PFCF: −7.34

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.00
-
0.13
22,919.37%
0.07
44.09%
0.10
43.42%
0.04
58.92%
cash conversion cycle
51.05K
-
64.67
99.87%
229.16
254.33%
121.22
47.10%
379.76
213.27%
cash per share
8.68
-
15.46
78.11%
4.84
68.69%
14.78
205.27%
2.45
83.41%
0.79
67.89%
1.14
45.08%
23.99
2,001.33%
7.40
69.15%
4.93
33.43%
2.06
58.13%
company equity multiplier
2.39
-
3.72
55.19%
3.95
6.32%
6.39
61.81%
6.19
3.13%
-1.69
127.37%
1.17
169.10%
1.03
11.87%
1.16
12.02%
1.21
5.00%
1.81
48.97%
days of inventory outstanding
57.70
-
66.31
14.92%
107.45
62.05%
71.21
33.73%
55.40
22.20%
days of payables outstanding
104.88
-
68.86
34.35%
52.55
23.68%
53.13
1.09%
45.69
14.00%
3.40K
-
days of sales outstanding
51.10K
-
67.22
99.87%
174.26
159.23%
103.14
40.81%
370.05
258.78%
dividend yield
0.01
-
0.01
7.31%
0.01
20.37%
ebit per revenue
-106
-
-0.22
99.80%
0.08
135.04%
-0.47
716.40%
-0.81
73.79%
ebt per ebit
1.31
-
0.84
35.73%
-6.67
891.66%
2.01
130.19%
1.31
35.16%
1.00
23.16%
1.07
7.11%
1.01
5.70%
1.00
1.81%
0.98
1.19%
0.97
0.91%
effective tax rate
0.14
-
-0.44
413.88%
1.11
354.27%
0.03
96.86%
1.13
3,147.79%
0.00
99.80%
0.09
3,794.15%
0.01
86.77%
0.00
99.54%
0.02
31,672.26%
enterprise value multiple
23.59
-
28.24
19.71%
13.28
52.99%
97.04
630.91%
12.58
87.03%
-49.85
496.23%
-20.00
59.89%
-0.02
99.88%
-2.95
11,718.52%
-2.69
8.59%
-2.92
8.30%
fixed asset turnover
0.00
-
0.45
49,667.43%
0.10
77.60%
0.19
90.16%
0.06
70.31%
free cash flow per share
0.77
-
-0.49
163.90%
-1.45
194.27%
2.71
287.37%
2.23
17.87%
-0.42
118.68%
-1.05
152.65%
-3.31
214.85%
-2.42
26.91%
-3.02
24.57%
-3.16
4.97%
gross profit margin
-380.67
-
0.22
100.06%
-1.41
743.28%
-0.67
52.44%
-4.79
615.76%
interest coverage
-3.28
-
-4.75
44.78%
0.12
102.47%
-1.02
973.60%
-0.67
34.68%
-959
143,284.47%
-148.10
-
-58.61
-
inventory turnover
6.33
-
5.50
12.98%
3.40
38.29%
5.13
50.89%
6.59
28.54%
long term debt to capitalization
0.47
-
0.70
48.30%
0.71
1.56%
0.81
14.01%
0.81
0.36%
0.07
-
0.09
28.42%
0.20
114.11%
net income per ebt
0.85
-
0.25
70.72%
-0.12
146.84%
0.96
921.54%
-0.14
114.68%
1
807.89%
0.91
8.90%
0.99
8.48%
1.00
1.19%
0.98
1.70%
1
1.73%
net profit margin
-118.67
-
-0.05
99.96%
0.06
229.93%
-0.91
1,628.67%
0.15
116.55%
operating cash flow per share
1.75
-
-0.49
128.12%
0.75
252.83%
5.24
596.85%
3.61
31.09%
-0.40
111.17%
-0.92
128.92%
-3.23
249.93%
-2.35
27.28%
-2.96
25.83%
-3.15
6.65%
operating cycle
51.16K
-
133.53
99.74%
281.71
110.97%
174.35
38.11%
425.45
144.02%
operating profit margin
-106
-
-0.22
99.80%
0.08
135.04%
-0.47
716.40%
-0.81
73.79%
payables turnover
3.48
-
5.30
52.31%
6.95
31.02%
6.87
1.08%
7.99
16.28%
0.11
-
pretax profit margin
-139
-
-0.18
99.87%
-0.51
177.41%
-0.94
86.07%
-1.06
12.68%
price fair value
1.08
-
1.00
7.89%
1.02
2.67%
1.51
47.62%
2.04
34.90%
-50.58
2,583.25%
21.83
143.15%
0.88
95.95%
1.64
86.13%
2.39
45.24%
8.70
264.26%
receivables turnover
0.01
-
5.43
75,914.81%
2.09
61.42%
3.54
68.96%
0.99
72.13%
return on assets
-0.07
-
-0.01
91.13%
0.00
172.64%
-0.09
2,292.35%
0.01
106.80%
-0.58
9,112.28%
-0.82
41.53%
-0.17
79.81%
-0.35
110.97%
-0.54
53.81%
-1.43
164.95%
return on capital employed
-0.07
-
-0.03
56.69%
0.01
119.80%
-0.05
983.83%
-0.04
27.13%
-0.63
1,551.27%
-0.98
54.78%
-0.17
82.56%
-0.38
120.64%
-0.61
62.57%
-2.12
245.75%
return on equity
-0.16
-
-0.02
86.24%
0.02
177.23%
-0.61
3,647.54%
0.04
106.58%
0.99
2,366.45%
-0.96
197.80%
-0.17
82.21%
-0.41
136.33%
-0.65
61.49%
-2.58
294.71%
total debt to capitalization
0.47
-
0.70
47.99%
0.71
1.76%
0.81
14.12%
0.82
0.16%
0.08
-
0.11
32.36%
0.23
114.29%

All numbers in USD (except ratios and percentages)